참고문헌
- Ambros V (2001). MicroRNAs: tiny regulators with great potential. Cell, 107, 823-6. https://doi.org/10.1016/S0092-8674(01)00616-X
- Bartel DP (2004). MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell, 116, 281-97. https://doi.org/10.1016/S0092-8674(04)00045-5
- Cai CK, Zhao GY, Tian LY, et al (2012). miR-15a and miR-16-1 downregulate CCND1 and induce apoptosis and cell cycle arrest in osteosarcoma. Oncol Rep, 28, 1764-70.
- Chen C, Ridzon DA, Broomer AJ, et al (2005). Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res, 33, 179. https://doi.org/10.1093/nar/gni178
- Chen Q, Xia HW, Ge XJ, et al (2013). Serum miR-19a predicts resistance to FOLFOX chemotherapy in advanced colorectal cancer cases. Asian Pac J Cancer Prev, 14, 7421-6. https://doi.org/10.7314/APJCP.2013.14.12.7421
- Cortez MA, Welsh JW, Calin GA (2012). Circulating microRNAs as noninvasive biomarkers in breast cancer. Recent Results Cancer Res, 195, 151-61. https://doi.org/10.1007/978-3-642-28160-0_13
- Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917. https://doi.org/10.1002/ijc.25516
- Garzon R, Heaphy CE, Havelange V, et al (2009). MicroRNA 29b functions in acute myeloid leukemia. Blood, 114, 5331-41. https://doi.org/10.1182/blood-2009-03-211938
- Guo J, Shou C, Meng L, et al (2007). Neuronal protein synuclein gamma predicts poor clinical outcome in breast cancer. Int J Cancer, 121, 1296-305. https://doi.org/10.1002/ijc.22763
- Harquail J, Benzina S, Robichaud GA (2012). MicroRNAs and breast cancer malignancy: an overview of miRNA-regulated cancer processes leading to metastasis. Cancer Epidemiol Biomarkers Prev, 11, 269-80.
- Huang F, Liu C, Shi YH, et al (2013). MicroRNA-101 inhibits cell proliferation, invasion, and promotes apoptosis by regulating cyclooxygenase-2 in Hela cervical carcinoma cells. Asian Pac J Cancer Prev, 14, 5915-20. https://doi.org/10.7314/APJCP.2013.14.10.5915
-
Jiang Y, Liu YE, Goldberg ID, et al (2004). A novel heat-shock protein-associated chaperone, stimulates ligand-dependent estrogen receptor
$\alpha$ signaling and mammary tumorigenesis. Cancer Res, 64, 4539-46. https://doi.org/10.1158/0008-5472.CAN-03-3650 - Jiang Y, Liu YE, Lu A, et al (2003). Stimulation of estrogen receptor signaling by gamma synuclein. Cancer Res, 63, 3899-903.
- Lian J, Zhang X, Tian H, et al (2009). Altered microRNA expression in patients with non-obstructive zoospermia. Reprod Biol Endocrinol, 7, 13. https://doi.org/10.1186/1477-7827-7-13
- Liu YE, Pu W, Jiang Y, et al (2007). Chaperoning of estrogen receptor and induction of mammary gland proliferation by neuronal protein synuclein gamma. Oncogene, 26, 2115-25. https://doi.org/10.1038/sj.onc.1210000
- Luo Q, Li X, Li J, et al (2013). MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer. Int J Oncol, 43, 1212-8.
- Ng SB, Yan J, Huang G, et al (2011). Dysregulated microRNAs affect pathways and targets of biologic relevance in nasaltype natural killer/T-cell lymphoma. Blood, 118, 4919-29. https://doi.org/10.1182/blood-2011-07-364224
-
Paik JH, Jang JY, Jeon YK, et al (2011). MicroRNA-146a Downregulates
$NF{\kappa}B$ Activity via Targeting TRAF6 and Functions as a Tumor Suppressor Having Strong Prognostic Implications in NK/T Cell Lymphoma. Clin Cancer Res, 17, 4761-71. https://doi.org/10.1158/1078-0432.CCR-11-0494 - Qin XJ, Ling BX (2012). Proteomic studies in breast cancer (Review). Oncol Lett, 3, 735-43.
- Shenouda SK, Alahari SK (2009). MicroRNA function in cancer: oncogene or a tumor suppressor? Cancer Metastasis Rev, 28, 369-78. https://doi.org/10.1007/s10555-009-9188-5
- Thorsen SB, Obad S, Jensen NF, et al (2012). The therapeutic potential of microRNAs in cancer. Cancer J, 18, 275-84. https://doi.org/10.1097/PPO.0b013e318258b5d6
- Valencia-Sanchez MA, Liu J, Hannon GJ, et al (2006). Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev, 20, 515-24. https://doi.org/10.1101/gad.1399806
- Wang H, Tan G, Dong L, et al (2012). Circulating MiR-125b as a marker predicting chemoresistance in breast cancer. PLoS One, 7, 34210. https://doi.org/10.1371/journal.pone.0034210
- Wei F, Xu J, Tang L, et al (2012). p27 (Kip1) V109G polymorphism and cancer risk: a systematic review and meta-analysis. Cancer Biother Radiopharm, 27, 665-71.
- Wu K, Quan Z, Weng Z, et al (2007). Expression of neuronal protein synuclein gamma gene as a novel marker for breast cancer prognosis. Breast Cancer Res Treatment, 101, 259-67. https://doi.org/10.1007/s10549-006-9296-7
- Yamanaka Y, Tagawa H, Takahashi N, et al (2009). Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia. Blood, 114, 3265-75. https://doi.org/10.1182/blood-2009-06-222794
- Yu Q, Liu SL, Wang H, et al (2013). miR-126 Suppresses the proliferation of cervical cancer cells and alters cell sensitivity to the chemotherapeutic drug bleomycin. Asian Pac J Cancer Prev, 14, 6569-72. https://doi.org/10.7314/APJCP.2013.14.11.6569
피인용 문헌
- MiR-492 contributes to cell proliferation and cell cycle of human breast cancer cells by suppressing SOX7 expression vol.36, pp.3, 2015, https://doi.org/10.1007/s13277-014-2794-z
- miR-365 overexpression promotes cell proliferation and invasion by targeting ADAMTS-1 in breast cancer vol.47, pp.1, 2015, https://doi.org/10.3892/ijo.2015.3015
- Downregulation of microRNA-497 is associated with upregulation of synuclein γ in patients with osteosarcoma vol.12, pp.6, 2016, https://doi.org/10.3892/etm.2016.3838
- MicroRNA-15a inhibits the growth and invasiveness of malignant melanoma and directly targets on CDCA4 gene vol.37, pp.10, 2016, https://doi.org/10.1007/s13277-016-5271-z
- Circulating long noncoding RNA GAS5 as a potential biomarker in breast cancer for assessing the surgical effects vol.37, pp.5, 2016, https://doi.org/10.1007/s13277-015-4568-7
- miR-15a-5p acts as an oncogene in renal cell carcinoma vol.15, pp.3, 2017, https://doi.org/10.3892/mmr.2017.6121
- MicroRNA-130b targets PTEN to mediate drug resistance and proliferation of breast cancer cells via the PI3K/Akt signaling pathway vol.7, pp.2045-2322, 2017, https://doi.org/10.1038/srep41942
- Downregulation of microRNA-15a suppresses the proliferation and invasion of renal cell carcinoma via direct targeting of eIF4E vol.38, pp.4, 2017, https://doi.org/10.3892/or.2017.5901